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1. Introduction 
The active transports of Na’ and K’ are done by 
Na’,K’-ATPase (EC 3.6.1.3) of the plasma membrane 
[l]. The enzyme, which requires Mg2+ and is inhib- 
ited by ouabain and related cardiac glycosides, is also 
considered to be the receptor for some, if not all, of 
the cardiac effects of these drugs [2]. Studies on the 
interaction of Ca*+ with this enzyme are of special 
interest because of the long-established interrelation 
between the effects of Ca*+ and cardiac glycosides on 
the heart [3]. Inhibition of enzyme activity by Ca*+, 
and the effects of Ca*’ on enzyme phosphorylation 
by ATP have been studied [2,4,5]. Na’,K’-ATPase is 
also phosphorylated by Pi in the presence of either 
Mg*+ or Mg*+ and ouabain [6-91. Here we report that 
the enzyme may also be phosphorylated by Pi in the 
presence of Ca*+, but that this process has an obliga- 
tory requirement for ouabain. The maximal level of 
phosphoenzyme formed with Pi + Ca** + ouabain is 
half of that obtained with Pi + Mg*+ + ouabain. The 
maximal level of bound ouabain is the same under 
both conditions. The findings provide support for 
Ca*+ + ouabaininduced half-of-the-sites reactivity in 
the oligomeric enzyme. 
2. Methods 
The highly purified enzyme of the dog kidney 
outer medulla was prepared and assayed as in [lo]. 
The specific activities of the various preparations used 
here were 900-l 500 ~01 ATP converted to 
Pi . mg-’ . h-‘. All phosphorylation experiments were 
done at 37°C with 0.1 mg enzyme protein suspended 
in 0.2 ml solution containing 20 mM Tris-HCl 
(PH 7.2), and the indicated concentrations of ligands. 
Measurement of acid-stable phosphoenzyme, and SDS 
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gel electrophoresis of the labeled enzyme, were done 
as in [lo]. Values for 32P-incorporation were cor- 
rected for 32P-incorporation into the denatured 
enzyme. The latter was <5% of the total as noted [9]. 
Ouabain binding to the enzyme was measured by 
conventional filtration techniques [2]. [3H]Ouabain 
and 32Pi were obtained from New England Nuclear 
(Boston MA). 32Pi was purified [ 1 l] immediately 
prior to use. 
3. Results 
Fig.1 shows the time-course of phosphorylation of 
the enzyme by Pi in the presence of Ca*+ and Mg*+. 
In agreement with [8,9], when Mg*+ is used a steady 
Mg”‘+Ouabain 
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Fig.1. Time-course of enzyme phosphorylation by Pi in the 
presence of Mgz+, Cal+ and ouabain. All reaction mixtures 
contained 0.2 mM 3*Pi and 0.5 mM EDTA. The ligands were 
added as indicated: 2 mM Mg’+; 2 mM Cal+; 0.1 mM ouabain. 
Other reaction conditions were as in section 2. The maximal 
level of ‘*P-incorporation was 3.1 nmol Pi/mg. 
215 
Volume 126, number 2 FEBS LETTERS April 1981 
-iP 
With Ouabain 
/ Without Ouabain 
___-_o___----__o--_----rJ- 
I 1 I I , de 
0 1 2 3 4 5 10 
Ca*+ (mM) 
Fig.2. Effects of varying concentrations of Ca2+ on enzyme 
phosphorylation by Pi in the presence or absorbence of oua- 
bain. Each incubation was done for 3 min under the condi- 
tions described in fig.1. All reactions mixtures contained 
0.5 mM EDTA. The enzyme preparation used here was that 
used in fig.1. 
state level of 32P-incorporation is attained in <l min 
regardless of the presence or absence of ouabain. 
With Ca*+, however, phosphorylation does not occur 
unless ouabain is also present. Ouabain without Ca*+ 
does not induce phosphorylation. Fig.2 shows that 
the [Ca*‘] used in fig.1 is optimal for Ca*+ + ouabain- 
induced phosphorylation. In separate experiments 
it was established that [ouabain], [Pi] and [Mg*+] 
used in fig.1 and 2 are also optimal (not shown). It 
is evident, therefore, that the maximal level of phos- 
phoenzyme obtained in the presence of Ca*+ + oua- 
bain is half of that obtained in the presence of 
Mg*+ + ouabain (fig.3, table 1). The data of fig.3 
show that Ca*+ + ouabaininduced phosphorylation 
and Mg*+ + ouabain-induced phosphorylation are not 
independent processes. When the phosphoenzyme is 
formed in the presence of ouabain and a low, but 
still optimal, [Mg*+]; and is then exposed to a high 
[Ca”‘], the phosphoenzyme level is reduced to that 
obtained with Ca*+ + ouabain. Conversely, when the 
phosphoenzyme is first formed in the presence of 
Ca*” and ouabain, and then exposed to Mg*+, the 
level rises and approaches that obtained in the pres- 
ence of Mg*+ + ouabain. With numerous combinations 
of [Ca”‘] and [Mg*+] other than those shown in fig.3, 
Mg2++0uabain 
0 1 2 3 4 5 
TIME (minutes) 
Fig.3. Relationship between Ca*+-induced and Mg2+-induced 
phosphorylation: (0) phosphorylation was initiated in the 
presence of 0.6 mM Mg*+ and ouabain; after 3 min 5 mM 
Ca’+ was added; (0) phosphorylation was initiated with 1 mM 
Ca’+ and ouabain; after 3 min 5 mM Mg*+ was added. Other 
conditions were as in 1ig.l. The maximal level of 32P-incorpo- 
ration in this enzyme preparation differing from fig.l.2, was 
2.6 nmol/mg. 
it was not possible to obtain a level of phosphoenzyme 
greater than that obtained with Mg*+ t ouabain. 
Similarities of the Ca*+-induced and the Mg*+- 
induced phosphoenzyme were also revealed by the 
following experiments for which data are not pre- 
Table 1 
Maximal levels of ouabain binding and “P-incorporation in 
the presence of Ca** or Mg’+ 
Reaction condition Phosphoenzyme Bound ouabain 
(nmol 32P/mg (nmol/mg 
protein) protein) 
Mg*+ + Pi + ouabain 2.19 f 0.02 2.07 r 0.13 
Ca*+ + Pi + ouabain 1.13 Y? 0.02 2.01 r 0.12 
Reaction conditions and &and concentrations were as 
described in legend to iig.1. In one set of reactions, 32Pi and 
unlabeled ouabain were used; and in the other unlabeled Pi 
and [3H]ouabain were used. Reaction time was 30 min. Val- 
ues of bound ouabain were corrected for non-specific binding 
to heatdenatured enzyme. Each indicated value is the aver- 
age and range of 6 separate experiments. The same enzyme 
preparation was used in all experiments. Note that this prepa- 
ration was different from the enzyme preparation used in 
experiments in fig. l-3 
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sented: When the enzyme was reacted with 32Pi + 
Ca*+ + ouabain, then subjected to SDS-polyacryl- 
amide gel electrophoresis at pH 2.4, ‘*P-label was 
detected only in the catalytic subunit (the o-subunit) 
of the enzyme. Exclusive labeling of this subunit 
upon reaction with Mg*+ + Pi has been shown [9]. 
In [ 1,2] the maximal level of ouabain binding to 
the purified enzyme occurred in the presence of 
Pi + Mg*+, and the no. ouabain molecules bound/unit 
of enzyme was the same as the no. Pi molecules 
incorp./unit of enzyme. The data of table 1 confirm 
this. Interestingly, however, the data show that when 
Mg*+ is replaced with Ca*+, 2 molecules of ouabain 
are bound for each Pi incorporated. 
4. Discussion 
The first points to be considered are the implica- 
tions of these findings in the context of the pharma- 
cologic effects of cardiac glycosides. There is now 
ample evidence to suggest hat the cardiac effects of 
these drugs may be due to their interactions with 
Na’,K’-ATPase [2]. It has also been known for 
decades that there is a synergism between the effects 
of Ca*+ and cardiac glycosides on the heart [3]. Stud- 
ies on the effects of Ca*+ and ouabain on the reac- 
tions of ATP with Na’,K’-ATPase, have provided no 
clues to suggest hat direct interactions of the 2 agents 
with Na’,K’-ATPase may be involved in the above 
synergism. Hence, the central theme of most current 
hypotheses on the mechanism of pharmacologic 
effects of cardiac glycosides is that these drugs inhibit 
the enzyme directly, but that alterations in mem- 
brane fluxes of Ca*+ are indicrect consequences of the 
functional inhibition of the enzyme [ 121. These data 
show that in vitro there is a functional state of the 
enzyme with obligatory requirement for Ca*+ and 
ouabain. Although the physiological significance of 
enzyme phosphorylation by Pi is not clear, the mere 
demonstration of such state of the enzyme indicates 
that serious attention should be paid to the possibil- 
ity of direct involvement of Na’,K’-ATPase in the 
mediation of the interrelated effects of Ca*+ and oua- 
bain in the intact tissue. 
The above considerations aside, these data are of 
help in the clarification of some uncertainties con- 
cerning the quaternary structure of Na’,K+-ATPase. A 
mainstay of the arguments for the existence of 22 
o-subunits in the functional unit of the enzyme has 
been the observation that only half of the cY-subunit 
content of the enzyme is phosphorylated in the pres- 
ence of either Mg*+ t Pi or Mg*+ + Na’ + ATP (e.g., 
[ 13,141). Due to inherent difficulties in the determi- 
nation of this stoichiometry, however, the possibility 
that in a rigorously purified enzyme all o-subunits 
may be phosphorylated under the above conditions 
has not been ruled out (e.g., [ 1.51). We now show that 
the replacement of Mg*+ with Ca*+ halves the maxi- 
mal level of the phosphoenzyme. This points to the 
existence of an cY-oligomer, regardless of how the 
above-mentioned uncertainties are resolved. If with 
Mg*+ all of the a-subunits are phosphorylated, then 
with Ca*+ half must be phosphorylated; suggesting a 
minimum of two associated o-subunits exhibiting 
ligand-induced half-of-the-sites reactivity with respect 
to phosphorylation, but not to ouabain binding. 
However, if half of the o-subunits are phosphorylated 
in the presence of Mg*+, one must conclude that the 
minimum structure is an ol-tetramer, and that in the 
presence of Ca*+ only one subunit is phosphorylated, 
and two bind ouabain. This pattern of ligand inter- 
action with the enzyme would be consistent with the 
results of crosslinking experiments on Na’,K’-ATPase 
which also suggest hat the existence of an cu-tetramer 
exhibiting ligand-induced negative cooperativity 
across 2 intersubunit domains [ 10,141. 
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